Altre lingue BioGend Therapeutics Co., Ltd.

Azioni

6733

TW0006733009

Prezzo di chiusura Taipei Exchange Altri mercati azionari 00:00:00 17/07/2024			Variaz. 5gg	Var. 1 gen.
37,7 ^TWD	+0,80%		-0,40%	-1,44%

28/05	BioGend Therapeutics Co., Ltd. annuncia che la fabbrica di Hsinchu ha superato la licenza di produzione del Sistema di Gestione della Qualita (Qms) dei dispositivi medici nazionali	CI
10/05	BioGend Therapeutics Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BioGend Therapeutics Co., Ltd. Announces Hsinchu Factory Pass the Domestic Medical Device Quality Management System Manufacturing License	28/05
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02/03
BioGend Therapeutics Co., Ltd. Receives Notification from the Thai FDA That Revocart to Obtains A Thai Medical Device License	06/02
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
BioGend Therapeutics Co., Ltd.(TPEX:6733) added to S&P Global BMI Index	18/09/23
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/05/23
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	10/08/22
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	11/05/22
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/11/21
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	09/08/21
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	09/05/21
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	15/03/21
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	09/11/20
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	12/08/20
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	28/04/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioGend Therapeutics Co., Ltd.

Azioni

6733

TW0006733009

Altre lingue

Filtri